Atrion Corporation

Equities

ATRI

US0499041053

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
465.2 ^USD	+2.06%		+4.47%	+22.83%

10/05	Atrion Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
10/05	Earnings Flash (ATRI) ATRION CORPORATION Posts Q1 Revenue $47.3M	MT

Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.

November 09, 2022 at 03:40 am IST

From July 1, 2022 to September 30, 2022, the company has repurchased 8,577 shares, representing 0.48% for $5.09 million. With this, the company has completed the repurchase of 99,960 shares, representing 5.48% for $57.29 million under the buyback announced on May 22, 2015.

Latest news about Atrion Corporation

Atrion Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	11/05	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q1 Revenue $47.3M	11/05	MT
Atrion Corporation Provides Production Guidance for the Third Quarter of 2024	11/05	CI
Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board	09/04	CI
Atrion Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01/03	CI
Earnings Flash (ATRI) ATRION CORPORATION Reports Q4 Revenue $43.6M	01/03	MT
Earnings Flash (ATRI) ATRION CORPORATION Posts Q4 EPS $3.65	01/03	MT
Atrion Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/03	CI
Atrion Keeps Quarterly Cash Dividend at $2.20 Per Share, Payable on March 29 to Shareholders of Record on March 15	28/02	MT
Atrion Corporation Declares Quarterly Cash Dividend, Payable on March 29, 2024	27/02	CI
North American Morning Briefing : S&P 500 Futures Ease From Nvidia-Inspired Record High	23/02	DJ
Atrion Corporation Enters into an Amended and Restated Credit Agreement	29/12	CI
Atrion Maintains Quarterly Dividend at $2.20 a Share, Payable Dec. 15 to Shareholders of Record on Dec. 1	13/11	MT
Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2023	13/11	CI
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.	08/11	CI
Atrion Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q3 Revenue $41.9M	08/11	MT
Atrion Corporation Announces Election of Jeannette Bankes as Director	21/23/21	CI
Atrion Increases Dividend to $2.20 a Share From $2.15, Payable on Sept. 29 to Shareholders as of Sept. 15	23/23/23	MT
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.	09/23/09	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q2 Revenue $43.8M	09/23/09	MT
Earnings Flash (ATRI) ATRION CORPORATION Posts Q2 EPS $3.73	09/23/09	MT
Atrion Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/23/09	CI
Atrion Retains Quarterly Dividend of $2.15 a Share, Payable June 30 to Shareholders of Record on June 15	24/23/24	MT
Atrion Corporation Declares Quarterly Dividend, Payable on June 30, 2023	24/23/24	CI

Chart Atrion Corporation

Duration

Period

More charts

Company Profile

Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Sector

Medical Equipment, Supplies & Distribution

Calendar

21/05/2024 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ATRION CORPORATION	+22.83%	802M
ABBOTT LABORATORIES	-5.43%	182B
MEDTRONIC PLC	+4.30%	114B
BECTON, DICKINSON AND COMPANY	-3.09%	68.38B
DEXCOM, INC.	+5.86%	52.46B
CENCORA, INC.	+8.15%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.79B

Other Medical Equipment, Supplies & Distribution